StemMed, Ltd. logo

StemMed, Ltd.

StemMed provides state-of-the-art pre-clinical drug testing services using a large panel of patient-derived xenograft (PDX) models of breast and pancreatic cancers. Breast cancer PDX models were developed from an ethnically diverse patient population, and represent all clinically-defined subtypes, including estrogen receptor positive (ER+), HER2+, and “triple-negative” cancers.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://stemmedcancer.com
Founded2009
Disease Focus
Development Stage
STOCK CODENon Listed
Address
7000 Fannin St., Suite 1960M, TX,77030
Houston
United States
Email
Contact Number
+1 832-413-1362

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/stemmed-ltd.” connections=”true” suffix=””]